Skip to Content

Tag: Respiratory Therapy


Eric Pauls

Also Noted

Inogen names Pauls to VP role 

September 9, 2024HME News Staff

GOLETA, Cailf. – Inogen has appointed Eric Pauls, formerly of Tactile Medical and Philips, as its vice president of sales, North America. “Eric’s extensive experience at Tactile Medical and Philips will be a powerful addition to our existing U.S. business-to-business and prescriber sales teams,” said Gregoire Ramade, chief commercial officer. “As we advance toward the introduction of Simeox to the U.S. market, Eric’s experience with the respiratory business will...

Eric Pauls, Inogen, Respiratory Therapy


Read Full Articlered right arrow icon

News

ALS report urges better access to respiratory care

June 27, 2024HME News Staff

WASHINGTON - The National Academies of Sciences, Engineering and Medicine have published “Living with ALS,” a report on improving the quality of care for individuals with ALS that includes specific recommendations to strengthen access to respiratory care.    The report includes a policy brief that urges CMS and private insurers to act quickly to expedite access to essential ALS medical and support services, including:  Requiring expedited (within 72 hours)...

Lou Gehrig's disease, Respiratory Therapy


Read Full Articlered right arrow icon

Boone Lockard

Also Noted

VGM names Lockard to lead respiratory division

April 12, 2022HME News Staff

WATERLOO, Iowa – VGM & Associates has named Boone Lockard, CRT, as its new director of VGM Respiratory. Lockard, who started his career as a respiratory therapist at Lehan Drugs, has more than 12 years of experience in the DME industry. He also worked on the manufacturer side with Philips Respironics for three years as a key account manager. “I am looking forward to working with the VGM membership on building additional value and navigating challenges in the industry,” said Lockard....

Boone Lockard, Respiratory Therapy, VGM & Associates, VGM Respiratory


Read Full Articlered right arrow icon

News

CQRC warns of possible access issues

March 18, 2022HME News Staff

WASHINGTON – Patient access to in-home respiratory care may be negatively impacted if a shortage in semiconductor chips is not addressed, warns the Council for Council for Quality Respiratory Care.  In a March 15 letter to Health and Human Services Secretary Xavier Becerra and U.S. Department of Commerce Secretary Gina Raimondo, CQRC and nine other respiratory care stakeholders urge the administration to use its authority to help address the shortage of semiconductor chips used in home...

Council for Quality Respiratory Care (CQRC), Oxygen Concentrator, Respiratory Therapy, semiconductor chips


Read Full Articlered right arrow icon

Vendors

Philips: Sales were down, orders were up in Q4, 2021

January 24, 2022HME News Staff

AMSTERDAM, the Netherlands – Philips’ comparable sales decreased 32% in the fourth quarter of 2021 for the Connected Care business due, in part, to a double-digit decline in Sleep & Respiratory Care associated with the recall.  For the full year, the Connected Care business recorded a 23% comparable sales decrease.  “Patient well-being is at the heart of everything we do at Philips, and we remain extremely focused on repairing and replacing the devices related to...

Philips earnings, Philips Recall, Respiratory Therapy, Sleep Therapy


Read Full Articlered right arrow icon

Also Noted

Study: RT home visits can reduce COPD readmissions

January 12, 2022HME News Staff

YARMOUTH, Maine - At-home interventions by a respiratory therapist can reduce hospital readmission rates among patients with COPD, according to a new study published in Respiratory Care. Study authors looked at outcomes in patients enrolled in a respiratory therapist-led COPD Disease Management Program, comparing outcomes of 658 patients who were discharged from five hospitals in the Atlantic Health System with outcomes of 435 patients who were discharged and then enrolled in the management program....

COPD, Readmissions, Respiratory Therapy


Read Full Articlered right arrow icon

Zach Gantt

Vendors

Encore is NEXUS between respiratory therapy, outcomes

December 17, 2021Liz Beaulieu, Editor

LIVINGSTON, Tenn. – With more than 27,000 patients now managed through NEXUS, Encore Healthcare was able to publish studies in CHEST and other journals recently that show its respiratory therapy management software improves outcomes.  Among the key take-aways from the studies: NEXUS can reduce hospital admissions by about 60% and it can improve medication management by about 41%.  “We’re at a tipping point,” said Zach Gantt,...

Encore Healthcare, Respiratory Therapy, Zach Gantt


Read Full Articlered right arrow icon

Providers

Quipt acquisition adds new vertical

November 23, 2021HME News Staff

CINCINNATI – Quit Home Medical has executed a non-binding letter of intent to acquire an “arm’s length” private respiratory care company servicing seven states throughout the U.S. reporting unaudited trailing 12-month annual revenues of about $14 million, $1 million in net income and positive adjusted EBITDA.  The acquisition adds a new vertical in long-term care settings, four new states and 165 remote respiratory therapists.  “We continue to strategically...

Mergers & Acquisitions (M&A), Quipt Home Medical, Respiratory Therapy


Read Full Articlered right arrow icon

Also Noted

AARC releases videos to thank RTs

June 24, 2021HME News Staff

IRVING, Texas – The American Association of Respiratory Care has released a series of new videos, “Thank a Respiratory Therapist,” to help increase community awareness of the profession and highlight the essential role RTs have played in patient care during COVID-19 and beyond. “Like many health care professionals working on the front lines of the pandemic, respiratory therapists worked tirelessly and selflessly to help patients everywhere,” said Sheri Tooley, president...

American Association for Respiratory Care (AARC), Respiratory Therapy


Read Full Articlered right arrow icon

Casey Hoyt

Specialty Providers

Viemed sees patient uploads rebound in March

May 4, 2021HME News Staff

LAFAYETTE, La. – Viemed Healthcare reported net revenues for its core business were $25.5 million for the first quarter ended March 31, 2021, a 12% increase compared to the same quarter last year.  Total revenues were $28.4 million, including $2.9 million for contract tracing services and product sales related to the COVID-19 pandemic.  “The first quarter will very likely be the quarter where things began to reopen from the COVID-19 pandemic and I am once again...

COVID-19, Financial Results, Respiratory Therapy, Viemed Healthcare


Read Full Articlered right arrow icon